ArticleDiscover oncology2025
Single-cell aggrephagy landscape delineates intercellular communication of tumor microenvironment associated with ovarian cancer progression and immunotherapy.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Single-cell RNA sequencing in ovarian cancer: decoding the tumor microenvironment for personalized therapy.Journal of ovarian research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Aggrephagy plays a pivotal role in ovarian cancer (OC) progression by clearing misfolded proteins. However, the functional role of aggrephagy within the tumor microenvironment (TME) remains elusive. Non-negative matrix factorization (NMF) was employed to analyze 43 aggrephagy-related genes (ARGs) on 65,820 single cells from scRNA-seq data of 12 samples (7 OC tissues and 5 normal tissues). The OC cohort from 9 public databases and TIDE-based immunotherapy scores were used to identify prognosis and immune response patterns of these TME cell clusters. Furthermore, the association between ARGs and CD8+ T cells was validated by the ID8 ovarian cancer mouse subcutaneous tumor model. Fibroblasts, T cells, macrophages and B cells identified from scRNA-seq of OC samples were subjected to biological process enrichment and classified based on ARGs expression patterns. Additionally, it revealed that ARGs may be significantly associated with clinical and biological characteristics of OC and pseudotime trajectories of major TME cell types. Bulk-seq analysis revealed that these aggrephagy-associated TME cell subsets were closely linked to the prognosis of OC patients and exhibited significant heterogeneity in predicting response to immunotherapy. Among them, CAF and CD8+ T cells showed particularly significant immune responsiveness. Notably, CellChat analysis revealed that aggrephagy-associated subtypes of TME cells engage in diverse and extensive interactions with tumor epithelial cells. Meanwhile, significant co-localization of TUBA1B with CD8+ T cells was observed in OC tissues from the mice model. This study is the first to delineate the role of aggrephagy regulators-mediated intercellular communication of the TME in regulating OC growth and antitumor immunomodulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.